What You Should Know: - Seven Bridges, a bioinformatics ecosystem provider, announced it is collaborating with the University of São Paulo (USP) and Google Cloud, as well as the Associação Genomas Brasil (Brazil Genome Association), to assist the DNA do Brasil (DNABr) project in building a reference genome that represents the genetic diversity of the Brazilian population. - The joint effort will advance unbiased precision medicine for underrepresented populations in Brazil through the
Read More
Potential of Implementing Polygenic Risk Scores in Healthcare Systems
The promise of personalized medicine is a world in which interventions, screening, and therapeutics are targeted to those most likely to get the disease. Polygenic risk scores will help society reach this ambition by accurately assessing the contribution that one’s DNA makes to disease risk. When Thomas Jefferson wrote in the Declaration of Independence that ‘all men are created equal,’ he captured the essential concept of equality on which the US Constitution is based. Although no one would
Read More
30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021. Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and selectivity of these models are outperforming AI models
Read More
Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap
Secondary bacterial or fungal co-infections in COVID-19 patients have received inadequate attention from the public. For most, co-infections pose little to no risk according to reports that an estimated 8% of patients are found to experience this during hospital admission – a relatively low number compared to the global impact of the virus. However, once a patient enters a hospital for care or becomes ventilated while in the ICU, the risk for acquiring and spreading a deadly
Read More
Using Health IT to Preserve Antibiotics and Fight Drug-Resistance
In its latest report on antibiotic resistance, the CDC revealed that infection rates for many threat pathogens are stagnant or in a nominal decline. While this is promising news, there are still a startling 2.8 million cases of drug-resistant infections predicted this year, which will result in an estimated 35,000 deaths. What’s more, the speed at which some patients are developing resistance to last-resort antibiotics – those that are often reserved for special scenarios and designed
Read More
5 Ways Artificial Intelligence Is Transforming Digital Pathology
- As the digital pathology market grows, facilities that rely on digital pathology will start using artificial intelligence (AI) to assist. AI could help health professionals cope with the gigantic quantities of data - Discover why healthcare facilities increasingly realize that AI could help achieve significant impacts with digital pathology.Thanks to approvals from the Food and Drug Administration (FDA) for applications such as primary disease diagnosis, digital pathology is rapidly becoming
Read More
StartUp Health Adds 6 New Healthcare Transformers to its Portfolio
StartUp Health, a platform where health transformers, partners, customers, investors, patients, and caregivers connect and accelerate the progress of the health moonshots announced it has added six new companies to its army of Healthcare Transformers.Every quarter, StartUp Health coaches its army of Health Transformers on how to create value, amplify their story, and ultimately achieve their Health Moonshot. Each company is supported for the entire journey of their business, through multiple
Read More
Genomic Analysis Startup Genoox Raises $6M to Expand in the US Market
Genoox, the genomic analysis company making it easier for doctors, clinicians, and researchers to analyze and act on genetic sequencing data has raised $6 million in funding led by Inimiti Capital Partners and Glilot Capital Partners. With this investment, Genoox will also be expanding their genomic services into the U.S. healthcare market, providing medical facilities with innovative solutions to help solve real and pressing healthcare problems. Genoox has an international footprint, with a
Read More
